Pharmaceutical Companies Starting to Adopt Track-and-Trace Systems
This article was originally published in The Gold Sheet
Executive Summary
The pharmaceutical industry is starting to implement new track-and-trace systems to monitor the movement of their drugs through the supply chain to comply with a California pedigree law that goes into effect in 2015. There are low expectations that a federally mandated track-and-trace program will be implemented by then.
You may also be interested in...
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.
US FDA Mulls Advance Notice On Domestic Surveillance Inspections Post-COVID
Criticized for giving foreign sites advance notice of inspections, agency is considering giving such notice to domestic sites too even after surprise inspections become possible.